<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-I53C231109K</udiDi>
    <basicUdiDi>B-I53C231109K</basicUdiDi>
    <tradeName>Vidermina MD PREBIOTIC ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I53C23110</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:59:51.791Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I53C30910AH</udiDi>
    <basicUdiDi>B-I53C30910AH</basicUdiDi>
    <tradeName>NEOVIDERM emulsione cutanea</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I53C30910</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:59:51.736Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I53C30920AL</udiDi>
    <basicUdiDi>B-I53C30920AL</basicUdiDi>
    <tradeName>NEOVIDERM emulsione cutanea</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I53C30920</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:59:51.707Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I53C30960AY</udiDi>
    <basicUdiDi>B-I53C30960AY</basicUdiDi>
    <tradeName>NEOVIDERM emulsione cutanea</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I53C30960</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:59:51.671Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I55V00000GR</udiDi>
    <basicUdiDi>B-I55V00000GR</basicUdiDi>
    <tradeName>Vidermina MD PREBIOTIC ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>VAGINAL DEVICES IN THE FORM OF SOLUTIONS/CREAMS/OVA/TABLETS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I55V00000</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:59:51.631Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I55V00030H2</udiDi>
    <basicUdiDi>B-I55V00030H2</basicUdiDi>
    <tradeName>Vidermina MD PREBIOTIC Vaginal Ovules</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I55V00030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:59:51.602Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-I58V00030JM</udiDi>
    <basicUdiDi>B-I58V00030JM</basicUdiDi>
    <tradeName>Vidermina MD LUBRIPIU' ovuli</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ISTITUTO GANASSINI S.p.A. di Ricerche Biochimiche</manufacturerName>
    <manufacturerSrn>IT-MF-000027942</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription></emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>I58V00030</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T22:59:51.561Z</lastUpdated>
  </row>
</eudamedExport>